Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database
Hatem Ali(National Research Centre), Shafi Malik(University Hospital Coventry), Tibor Fülöp(Medical University of South Carolina), Mahmoud Mohammed(University of Mississippi)
Cited by 9
Related Papers
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156
Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
|Molecular Psychiatry|2014|129
Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC Study
|American Journal of Epidemiology|2009|119